Back to entry
Report this entry
Let us know what's wrong. We'll take a look and act if needed.
MAPS addresses progress in FDA discussions on MDMA-assisted therapy for PTSD and outlines regulatory steps, safety oversight, and the path toward potential resubmission
maps.org